First Trust Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.3M | Buy |
81,214
+45,613
| +128% | +$2.98M | ﹤0.01% | 1331 |
|
|
2025
Q1 | $2.38M | Buy |
35,601
+3,070
| +9% | +$206K | ﹤0.01% | 1707 |
|
|
2024
Q4 | $1.8M | Sell |
32,531
-4,876
| -13% | -$270K | ﹤0.01% | 1852 |
|
|
2024
Q3 | $2.23M | Sell |
37,407
-24,372
| -39% | -$1.45M | ﹤0.01% | 1739 |
|
|
2024
Q2 | $3.93M | Buy |
+61,779
| New | +$3.93M | ﹤0.01% | 1388 |
|
|
2020
Q1 | – | Sell |
-22,584
| Closed | -$1.39M | – | 2348 |
|
|
2019
Q4 | $1.39M | Buy |
+22,584
| New | +$1.39M | ﹤0.01% | 1735 |
|
|
2019
Q3 | – | Sell |
-15,392
| Closed | -$1.27M | – | 2390 |
|
|
2019
Q2 | $1.27M | Buy |
15,392
+270
| +2% | +$22.2K | ﹤0.01% | 1769 |
|
|
2019
Q1 | $1.07M | Buy |
15,122
+179
| +1% | +$12.6K | ﹤0.01% | 1836 |
|
|
2018
Q4 | $673K | Buy |
14,943
+2,378
| +19% | +$107K | ﹤0.01% | 2012 |
|
|
2018
Q3 | $710K | Buy |
+12,565
| New | +$710K | ﹤0.01% | 2062 |
|
|
2016
Q2 | – | Sell |
-17,964
| Closed | -$605K | – | 2274 |
|
|
2016
Q1 | $605K | Sell |
17,964
-7,382
| -29% | -$249K | ﹤0.01% | 1865 |
|
|
2015
Q4 | $1.14M | Sell |
25,346
-6,935
| -21% | -$313K | ﹤0.01% | 1683 |
|
|
2015
Q3 | $1.28M | Sell |
32,281
-23,337
| -42% | -$922K | ﹤0.01% | 1633 |
|
|
2015
Q2 | $3.45M | Buy |
+55,618
| New | +$3.45M | 0.01% | 1201 |
|